Short-Term Outcomes of SILS+1 Versus CLS for Distal Gastric Cancer

A Prospective Randomized Controlled Trial of the Short-Term Efficacy of Single-Hole Plus One-Hole Total Laparoscopic Surgery Versus Five-Hole Total Laparoscopic Surgery for Distal Gastric Cancer

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100051491

Enrollment

Unknown

Registered

2021-09-24

Start date

2021-10-01

Completion date

Unknown

Last updated

2022-06-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastric cancer

Interventions

Experimental group:SILS + 1

Control group:CLS

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. The patients aged 18 to 75 years; 2. Pathological diagnosis of gastric cancer; 3. Clinical diagnosis of cT1b-3N0-2M0 lesions (measured by abdominal CT) according to the eighth edition of the AJCC Tumor Staging Manual; 4. Tumor size <=5cm; 5. Subtotal gastrectomy is planned.

Exclusion criteria

Exclusion criteria: 1. Preoperative radiotherapy and chemotherapy; 2. Tumor perforation; 3. Severe mental illness.

Design outcomes

Primary

Measure	Time frame
Rate of complications;	—

Secondary

Measure	Time frame
Rate of death;pain intensity;	—

Countries

China

Contacts

Public ContactTeng Wenhao

Fujian Cancer Hospital

fjtengwh@163.com+86 13600815361

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 13, 2026